Live vaccine is bacterium or virus to make its mutation in artificial condition, lose pathogenicity but retain immunogenicity and reproduction ability and remaining virulence, after vaccinating, there is the reproduction or replication of certain level inside human body, resemble a light natural infection process, but won't cause a person to come on.
This report contains market size and forecasts of Live Vaccines in global, including the following market information:
Global Live Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Live Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Live Vaccines companies in 2021 (%)
The global Live Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monovalent Live Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Live Vaccines include Merck, GlaxoSmithKline, Pfizer, Novartis, Astellas Pharma, Emergent BioSolutions and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Live Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Live Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Live Vaccines Market Segment Percentages, by Type, 2021 (%)
Monovalent Live Vaccines
Multivalent Live Vaccines
Global Live Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Live Vaccines Market Segment Percentages, by Application, 2021 (%)
Adults
Children
Global Live Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Live Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Live Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Live Vaccines revenues share in global market, 2021 (%)
Key companies Live Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Live Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GlaxoSmithKline
Pfizer
Novartis
Astellas Pharma
Emergent BioSolutions
AstraZeneca